BPC-157 Dosing for Tendon Repair Common Protocols Conservative approach (8-week cycle): Dose: 250-500mcg per day Route: Subcutaneous injection Frequency: Daily Duration: 8-12 weeks Break: 4 weeks between cycles Aggressive approach (ongoing): Dose: 500mcg daily for 6 weeks Then: 250mcg 2-3x weekly maintenance Route: Subcutaneous or intranasal Duration: Continuous until injury resolved Localized injection (advanced): Direct injection into injured tendon (medical supervision required) Dose: 250-500mcg Frequency: 1-2x weekly Duration: 4-8 weeks Results: May be superior, but requires qualified practitioner Administration Routes Subcutaneous (most common): 250-500mcg in 0.5mL water, injected daily Painless, stable delivery Consistent blood levels Intranasal: 250mcg sprayed into nostrils daily Non-invasive, good absorption Less evidence but growing anecdotal support Oral: Limited effectiveness (degraded by stomach acid) Not recommended for serious injury recovery Real-World Results: Athlete Case Studies Case 1: Chronic Patellar Tendinopathy (Runner) Situation : 3 years of patellar tendon pain, limiting running to 3 miles max Protocol : BPC-157: 500mcg daily for 8 weeks Eccentric loading exercises 3x weekly Return to training protocol structured over 12 weeks Result : After 4 months, pain-free running at pre-injury distances
This democratization of peptide access will bring these compounds to people who never would have started an injection-based protocol
The BPC-157 identity is defined first by its 15-residue sequence
Anti-Inflammatory Effects: TB-500 may blunt inflammation at a broader level, potentially easing whole-body soreness and joint stiffness useful for women in high-intensity sports or during perimenopause, when inflammation may already be higher
[DOI] [PMC free article] [PubMed] [Google Scholar] 220.Cheetham SC, Jackson HC, Vickers SP, Dickinson K, Jones RB, Heal DJ
Description Additional information BPC-157 is a high-purity research supplied in lyophilized form
